WallStSmart

Empro Group Inc. Ordinary shares (EMPG)vsQuipt Home Medical Corp (QIPT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Quipt Home Medical Corp generates 4731% more annual revenue ($264.97M vs $5.48M). EMPG leads profitability with a 13.7% profit margin vs -4.0%. EMPG earns a higher WallStSmart Score of 47/100 (D+).

EMPG

Hold

47

out of 100

Grade: D+

Growth: 5.3Profit: 9.0Value: 3.0Quality: 8.5
Piotroski: 6/9Altman Z: 3.11

QIPT

Hold

40

out of 100

Grade: D

Growth: 7.3Profit: 2.5Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EMPGSignificantly Overvalued (-2745.9%)

Margin of Safety

-2745.9%

Fair Value

$0.61

Current Price

$17.36

$16.75 premium

UndervaluedFair: $0.61Overvalued

Intrinsic value data unavailable for QIPT.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EMPG4 strengths · Avg: 10.0/10
Return on EquityProfitability
66.3%10/10

Every $100 of equity generates 66 in profit

Operating MarginProfitability
36.1%10/10

Strong operational efficiency at 36.1%

Revenue GrowthGrowth
141.6%10/10

Revenue surging 141.6% year-over-year

Altman Z-ScoreHealth
3.1110/10

Safe zone — low bankruptcy risk

QIPT2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
32.0%10/10

Revenue surging 32.0% year-over-year

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

Areas to Watch

EMPG4 concerns · Avg: 3.3/10
Price/BookValuation
17.0x4/10

Trading at 17.0x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$143.05M3/10

Smaller company, higher risk/reward

P/E RatioValuation
192.9x2/10

Premium valuation, high expectations priced in

QIPT4 concerns · Avg: 2.5/10
Market CapQuality
$162.30M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
1.5%3/10

Operating margin of 1.5%

Return on EquityProfitability
-9.3%2/10

ROE of -9.3% — below average capital efficiency

EPS GrowthGrowth
-97.7%2/10

Earnings declined 97.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : EMPG

The strongest argument for EMPG centers on Return on Equity, Operating Margin, Revenue Growth. Revenue growth of 141.6% demonstrates continued momentum.

Bull Case : QIPT

The strongest argument for QIPT centers on Revenue Growth, Price/Book. Revenue growth of 32.0% demonstrates continued momentum.

Bear Case : EMPG

The primary concerns for EMPG are Price/Book, EPS Growth, Market Cap. A P/E of 192.9x leaves little room for execution misses.

Bear Case : QIPT

The primary concerns for QIPT are Market Cap, Operating Margin, Return on Equity.

Key Dynamics to Monitor

EMPG profiles as a growth stock while QIPT is a hypergrowth play — different risk/reward profiles.

EMPG is growing revenue faster at 141.6% — sustainability is the question.

QIPT generates stronger free cash flow (7M), providing more financial flexibility.

Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

EMPG scores higher overall (47/100 vs 40/100) and 141.6% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Empro Group Inc. Ordinary shares

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Empro Group Inc., through its subsidiary, sells healthcare and beauty products in Malaysia and internationally. The company is headquartered in Shah Alam, Malaysia.

Visit Website →

Quipt Home Medical Corp

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.

Want to dig deeper into these stocks?